Norway· NO-ID_FFE9C1D4-A811-44D4-A7ED-4C1ACD8962D7
Rozlytrek
A entrectinib product containing entrectinib, registered in Norway by Roche Registration GmbH. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Entrectinib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EX14 (entrectinib), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Entrectinib · ATC L01EX14
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of entrectinib costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Entrectinib · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$216.58
The record
At a glance
FEST (Norway)- Active substance
- Entrectinib
- Manufacturer
- Roche Registration GmbH
- Country
- Norway (NO)
- ATC code
- L01EX14
- ATC class
- Entrectinib
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_FFE9C1D4-A811-44D4-A7ED-4C1ACD8962D7
- no_varenummer47999242NOK 19746.8
- gtin7613326094832
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
570 interactions on record for entrectinib.
Graded by severity as the source publishes them — 151 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Entrectinib · interactions on record
570 records
- 151 severe
- 405 moderate
- 14 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- AprepitantA04AD12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Entrectinib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENTRECTINIB
- SpainROZLYTREK 50 MG GRANULADO RECUBIERTO CON PELICULA EN SOBRERoche Registration Gmbh
- FinlandRozlytrekRoche Registration GmbH
- IrelandRozlytrek 50 mg film-coated granules in sachetRoche Registration GmbH
- NetherlandsRozlytrek 50 mg filmomhuld granulaat in sachetRoche Registration GmbH
- PolandRozlytrekRoche Registration GmbH
- BelgiumRozlytrek 50 mgRoche Registration
- SwedenRozlytrek 50 mg Filmdragerat granulat i dospåseRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Rozlytrek
- Liechtenstein · Rozlytrek
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c0be7ba4-38ca-42df-bb26-91ce725ef60c GET /v1/drugs/c0be7ba4-38ca-42df-bb26-91ce725ef60c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granulat, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Entrektinib",
"merkevare_id": "ID_FFE9C1D4-A811-44D4-A7ED-4C1ACD8962D7",
"name_form_strength": "Rozlytrek gran filmdrasjert 50 mg",
"prescription_group": "C"
}See everything about entrectinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.